Uploaded on Apr 8, 2024
According to the latest research report by IMARC Group, The global cancer cachexia market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. More Info:- https://www.imarcgroup.com/cancer-cachexia-market
Cancer Cachexia Market Growth, Demand and Challenges of the Key Industry Players 2024-32
Global Cancer Cachexia Market Research and Forecast Report 2024- 2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved About IMARC Group In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and t ransform thei r bus inesses. IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls , chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods are at the top of the company’s exper t ise. IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure las t ing resul ts . A cc o r d i ng t o t h e l a t e s t r e p o r t b y I MA R C Gr o u p , t i t l e d " C a n c e r C a c h e x i a Ma r k e t : G l o b a l I n d u s t r y T r e n d s , S h a r e , S i z e , Gr o w th , O p p o r t u n i t y a n d F o r e c as t 2 0 2 4 - 20 3 2 , " t h e g l o b a l c a n c e r c a c h ex i a ma r k e t s i z e re a c h e d U S $ 2 .1 B i l l i o n i n 2 0 23 . C an c e r c a c he x i a i s a me t a bo l i c d i s e a s e c h a r a c t e r i z e d b y m u s c l e ma s s a n d f a t l o s s , f a t i g u e , a n d w e a kn e s s . I t i s a co m m on an d s e v e re co m p l i c a t i o n o f c an c e r , a f f e c t i n g u p Report t o 8 0 % o f a d v a n ce d c a n c e r pa t i e n ts , a n d i s a s i g n i f i ca n t c o n t r i bu t o r t o m o r b i d i t y a nd mo r t a l i t y i n t h i s p op u l a t i o n . C a c h e x i a i s a m u l t i f a c t o r i a l s y n d ro m e r es u l t i n g f r o m an i mb a l a n ce b e t w ee n e n e r g y i n ta k e a nd e x p en d i t u r e , l e a d i n g t o p r o g r es s i v e m u sc l e Highlight and w as t i n g a n d a no r e x i a . I t i s n o t s i m p l y a r e su l t o f p o o r a pp e t i t e o r nu t r i t i o na l i n t a k e b u t a sy s t e m i c Description ma n i f e s ta t i o n o f u n d e r l y i n g c a nc e r a n d i t s me t a b o l i c e f f e c t s . T he u nd e r l y i n g me c h a n i sm s o f c a n c e r c a c he x i a i n vo l v e a c o m p l e x i n t e rp l a y o f f a c to r s , i n c l u d i n g cy t o k i n e p r o d uc t i o n , o x i d a t i v e s t r e ss , a n d h o r mo n a l i m ba l a n c es . C a n c e r c a c he x i a a l s o s i gn i f i c a n t l y i mp a c ts t he i m mu n e s y s te m a nd c a n i m pa i r t h e e f f e c t i v en e s s o f c a n c e r t r e a t me n t . R eq u e s t f o r a P D F sa m p le o f th i s r ep o r t : h t t p s : / /w w w . i ma r c g r o u p . co m / ca n c e r - ca c h e x i a - m a rk e t / re q u e s ts a m p l e Report Description Global Cancer Cachex ia Market T rends: The g loba l m arke t i s ma jo r l y d r i ven by t he inc reas ing preva lence o f cancer . I n l i ne w i th th i s , t he r i s ing demand f o r e f fec t i ve t rea tmen ts i s s ign i f i can t l y con t r ibu t i ng t o the marke t g rowth . Fur thermore , t he g row ing demand f o r t he rapy drugs and heavy inves tmen ts in research and deve lopment ac t i v i t i es to i n t r oduce new therapeu t i c d rugs a re pos i t i ve ly in f luenc ing the marke t . Apar t f r om th is , t he esca la t ing hea l thcare expend i tu re and improv ing hea l thcare in f ras t ruc tu re a re ca ta lyz ing t he marke t . Moreover , t he rap id adop t ion o f combina t i on therap ies among t he pa t i en t popu la t ion i s f avo r ing t he marke t expans ion . Bes ides , t he i nc reas ing ge r i a t r i c popu la t ion and the w idesp read ava i lab i l i t y o f nove l t he rapeu t i c d rugs to t rea t cancer cachex ia a re p rope l l i ng the marke t . Add i t i ona l l y , f avo rab le in i t i a t i ves under taken by the gove rnmen ts ac ross var ious coun t r ies to spread awareness rega rd ing cancer cachex ia a re p rov id ing a boos t t o t he marke t . Look ing fo rward , the market i s an t i c i pa ted to reach a va lue o f US$ 3 . 0 B i l l i on by 2032, exh ib i t ing a CAGR o f 4 . 1% dur ing 2024-2032 . V i ew Report TOC, F igures and Tab les : h t tps: / / www. i marcgroup .com/cancer -cachexi a-market Breakup by Therapeutics: • Progestogens • Cort icosteroids • Combinat ion Therapy • Others Report Breakup by Mode of Action: Segmentation • Appetite St imulators • Weight Loss Stabi l izers Breakup by Distribution Channel: • Hospita l Stores • Retai l Pharmacy • Onl ine Pharmacy Breakup by Region: • North America • Asia-Pacifi c • Europe • Latin America Report • Middle East and Afr ica Segmentation • AAVogen Inc. • Actimed Therapeutics Ltd. • Aphios Corporation • Competitive Artelo Biosciences Inc. • AVEO Pharmaceuticals Inc. Landscape • Fresenius Kabi AG (Fresenius SE & Co. with Key KGaA) • Helsinn Healthcare SA Players • Merck & Co. Inc. • NGM Biopharmaceuticals Inc. • Pfi zer Inc. • Tetra Bio-Pharma What was the size of the global cancer cachexia market in 2023? What is the expected growth rate of the global cancer cachexia market during 2024-2032? What are the key factors driving the global cancer Key cachexia market? Questions What has been the impact of COVID-19 on the global cancer cachexia market? Answered in What is the breakup of the global cancer cachexia the Report market based on the therapeutics? What is the breakup of the global cancer cachexia market based on the mode of action? What are the key regions in the global cancer cachexia market? Who are the key players/companies in the global cancer cachexia market? 1 P r e f a c e 2 S c o p e a n d M e t h o d o l o g y 2 . 1 O b j e c t i v e s o f t h e S t u d y 2 . 2 S t a k e h o l d e r s 2 . 3 D a t a S o u r c e s 2 . 3 . 1 P r i m a r y S o u r c e s 2 . 3 . 2 S e c o n d a r y S o u r c e s 2 . 4 M a r k e t E s t i m a t i o n Table of 2 . 4 . 1 B o t t o m - U p A p p r o a c h 2 . 4 . 2 T o p - D o w n A p p r o a c h 2 . 5 F o r e c a s t i n g M e t h o d o l o g y 3 E x e c u t i v e S u m m a r y 4 I n t r o d u c t i o n Contents 4 . 1 O v e r v i e w 4 . 2 K e y I n d u s t r y T r e n d s5 G l o b a l C a n c e r C a c h e x i a M a r k e t 5 . 1 M a r k e t O v e r v i e w 5 . 2 M a r k e t P e r f o r m a n c e 5 . 3 I m p a c t o f C O V I D - 1 9 5 . 4 M a r k e t F o r e c a s t 6 M a r k e t B r e a k u p b y T h e r a p e u t i c s 6 . 1 P r o g e s t o g e n s 6 . 1 . 1 M a r k e t T r e n d s 6 . 1 . 2 M a r k e t F o r e c a s t 6 . 2 C o r t i c o s t e r o i d s 6 . 2 . 1 M a r k e t T r e n d s 6 . 2 . 2 M a r k e t F o r e c a s t 6 . 3 C o m b i n a t i o n T h e r a p y 6 . 3 . 1 M a r k e t T r e n d s 6 . 3 . 2 M a r k e t F o r e c a s t 6 . 4 O t h e r s 6 . 4 . 1 M a r k e t T r e n d s 6 . 4 . 2 M a r k e t F o r e c a s t 7 M a r k e t B r e a k u p b y M o d e o f A c t i o n 7 . 1 A p p e t i t e S t i m u l a t o r s 7 . 1 . 1 M a r k e t T r e n d s 7 . 1 . 2 M a r k e t F o r e c a s t 7 . 2 W e i g h t L o s s S t a b i l i z e r s 7 . 2 . 1 M a r k e t T r e n d s 7 . 2 . 2 M a r k e t F o r e c a s t Table of 8 M a r k e t B r e a k u p b y D i s t r i b u t i o n C h a n n e l 8 . 1 H o s p i t a l S t o r e s 8 . 1 . 1 M a r k e t T r e n d s 8 . 1 . 2 M a r k e t F o r e c a s t Contents 8 . 2 R e t a i l P h a r m a c y 8 . 2 . 1 M a r k e t T r e n d s 8 . 2 . 2 M a r k e t F o r e c a s t 8 . 3 O n l i n e P h a r m a c y 8 . 3 . 1 M a r k e t T r e n d s 8 . 3 . 2 M a r k e t F o r e c a s t 9 M a r k e t B r e a k u p b y R e g i o n 9 . 1 N o r t h A m e r i c a 9 . 1 . 1 U n i t e d S t a t e s 9 . 1 . 1 . 1 M a r k e t T r e n d s 9 . 1 . 1 . 2 M a r k e t F o r e c a s t 9 . 1 . 2 C a n a d a 9 . 1 . 2 . 1 M a r k e t T r e n d s 9 . 1 . 2 . 2 M a r k e t F o r e c a s t F o r m o r e i n f o r m a t i o n , v i s i t : h t t p s : / / w w w. im a rcg ro u p . co m / c a n ce r- ca c h ex ia - m a r ke t / t o c Disclaimer © 2023 IMARC Al l R ights Reserved Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing , reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) . Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r i naccu rac ies i f any f ound th is pub l i ca t ion . IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re reg i s te red t rademarks o f t he i r r espec t i ve compan ies . Contact Us Visit us at : https://www.imarcgroup.com TELEPHONE: +1-631-791-1145 E-MAIL: [email protected]
Comments